2、C3、C23、C28衍生物,并對其體外抗腫瘤活性進(jìn)行研究.方法 以天然產(chǎn)物積雪草酸為先導(dǎo)化合物,對C2、C3、C23位羥基及C28位羧基進(jìn)行結(jié)構(gòu)改造,并采用SRB法對目標(biāo)化合物進(jìn)行初步的體外抗腫瘤活性研究.結(jié)果 設(shè)計并合成了目標(biāo)化合物,利用MS及1H-NMR確證了結(jié)構(gòu);體外實驗中,積雪草酸衍生物的抗腫瘤活性明顯高于積雪草酸,并優(yōu)于對照藥吉非替尼.結(jié)論 積雪草酸衍生物具有良好的抗腫瘤活性,值得進(jìn)一步研究.;Objective To design and synthesize asiatic acid C2, C3, C23, and C28 derivatives, and to study their antitumor activities in vitro. Methods Asiatic acid was used as starting material to synthesize the target compounds by structural modification at C2, C3, and C23 hydroxyl groups, and C28 carboxyl group. The antitumor activities of the compounds were tested by SRB assay. Results The target compounds were synthesized and characterized by MS and 1H- NMR. The in vitro antitumor activity experiments showed that the antitumor activity of asiatic acid derivatives were higher than those of asiatic acid in vitro, and were better than control drug gefitinib. Conclusion Asiatic acid derivatives have good antitumor activities which could be a valuable candidate for further development."/>

久久久久亚洲精品,久久无码av三级,娇妻借朋友高h繁交h,久久男人av资源站,狠狠久久五月精品中文字幕

首頁 > 過刊瀏覽>2015年第30卷第4期 >2015,30(4):355-361. DOI:10.7501/j.issn.1674-5515.2015.04.002
上一篇 | 下一篇

積雪草酸C2、C3、C23、C28衍生物的合成及其體外抗腫瘤活性研究

Synthesis of asiatic acid C2, C3, C23, and C28 derivatives and their antitumor activities in vitro

發(fā)布日期：2015-04-23
  • 摘要
  • 圖/表
  • 訪問統(tǒng)計
  • PDF預(yù)覽
  • 參考文獻(xiàn)
  • 相似文獻(xiàn)
  • 引證文獻(xiàn)
  • 附件
    [關(guān)鍵詞]
    [摘要]
    目的 設(shè)計并合成積雪草酸C2、C3、C23、C28衍生物,并對其體外抗腫瘤活性進(jìn)行研究.方法 以天然產(chǎn)物積雪草酸為先導(dǎo)化合物,對C2、C3、C23位羥基及C28位羧基進(jìn)行結(jié)構(gòu)改造,并采用SRB法對目標(biāo)化合物進(jìn)行初步的體外抗腫瘤活性研究.結(jié)果 設(shè)計并合成了目標(biāo)化合物,利用MS及1H-NMR確證了結(jié)構(gòu);體外實驗中,積雪草酸衍生物的抗腫瘤活性明顯高于積雪草酸,并優(yōu)于對照藥吉非替尼.結(jié)論 積雪草酸衍生物具有良好的抗腫瘤活性,值得進(jìn)一步研究.
    [Key word]
    [Abstract]
    Objective To design and synthesize asiatic acid C2, C3, C23, and C28 derivatives, and to study their antitumor activities in vitro. Methods Asiatic acid was used as starting material to synthesize the target compounds by structural modification at C2, C3, and C23 hydroxyl groups, and C28 carboxyl group. The antitumor activities of the compounds were tested by SRB assay. Results The target compounds were synthesized and characterized by MS and 1H- NMR. The in vitro antitumor activity experiments showed that the antitumor activity of asiatic acid derivatives were higher than those of asiatic acid in vitro, and were better than control drug gefitinib. Conclusion Asiatic acid derivatives have good antitumor activities which could be a valuable candidate for further development.
    [中圖分類號]
    [基金項目]
    國家自然科學(xué)基金資助項目(21372156);遼寧省教育廳高等學(xué)校優(yōu)秀人才支持計劃資助項目(LR2013017);沈陽市科技計劃資助項目(F13-316-1-47)